muscle soreness with tirzepatide Body Aches: Clinical Evidence & Safety – PlexusDx Can Mounjaro™ (Tirzepatide) Cause Body

Intramuscular injections, delivered deep into the muscle tissue, are absorbed much more rapidly

FDAs Mai Tu concurred that this peptide is not well-characterized. The briefing materials also note that FDA staff has received three adverse event (AE) reports following BPC-157 injection: a 55-year-old woman reported use of BPC-157 injection and reported nine days of redness and swelling around the injection site

Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed

The main driver of the gap is the data collection periods for the individual measures which is outside the purview of the Overall Hospital Quality Star Rating methodology, and often necessary as longer periods are needed for smaller volume hospitals